Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 5/20 | 0.46 |
| ▸ | SRD5A1 | P18405 | 4/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12365963 | 0.88 | SRD5A2 (0.39) | SRD5A2SRD5A1TTRPTPRCALDH1A1 | |
| SCHEMBL12365322 | 0.88 | SRD5A2 (0.38) | SRD5A2SRD5A1ALDH1A1HPGDKDM4E | |
| SCHEMBL12365025 | 0.86 | PDK2 (0.40) | PTPRCALDH1A1KMT2APDK2HPGD | |
| SCHEMBL12366052 | 0.85 | SRD5A2 (0.49) | SRD5A2SRD5A1TTRALDH1A1TDP2 | |
| SCHEMBL12365096 | 0.85 | MAPK14 (0.42) | SRD5A2SRD5A1TTRALDH1A1TDP2 | |
| SCHEMBL12365878 | 0.84 | MAPK14 (0.39) | SRD5A2SRD5A1ALDH1A1KMT2ANOTUM | |
| SCHEMBL12366688 | 0.84 | HTR2B (0.49) | — | |
| SCHEMBL12365949 | 0.82 | TTR (0.38) | SRD5A2SRD5A1TTRALDH1A1PDK2 | |
| SCHEMBL12365323 | 0.82 | KDM4E (0.43) | SRD5A2SRD5A1ALDH1A1KMT2AKDM4E | |
| SCHEMBL12365492 | 0.82 | SRD5A2 (0.43) | SRD5A2SRD5A1TTRPTPRCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110207729-A1 | BICYCLIC ACYLGUANIDINE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207729-A1 | BICYCLIC ACYLGUANIDINE DERIVATIVE | HTR5A, HTR2A, HTR1E | SRD5A2 412/4885SRD5A1 247/4885TTR 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.